{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:22:20Z","timestamp":1773868940083,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T00:00:00Z","timestamp":1283990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00415-010-5738-6","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T12:28:26Z","timestamp":1283948906000},"page":"255-262","source":"Crossref","is-referenced-by-count":28,"title":["Tau and 14-3-3 of genetic and sporadic Creutzfeldt\u2013Jakob disease patients in Israel"],"prefix":"10.1007","volume":"258","author":[{"given":"Zeev","family":"Meiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Kahana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Baitcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos D.","family":"Korczyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Milo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Aharon-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oded","family":"Abramsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Rosenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"5738_CR1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","volume":"353","author":"A Alperovitch","year":"1999","unstructured":"Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt\u2013Jakob disease. Lancet 353:1673\u20131674","journal-title":"Lancet"},{"key":"5738_CR2","doi-asserted-by":"crossref","unstructured":"Buerger K, Otto M, Teipel SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schr\u00f6der J, Sch\u00f6nknecht P, Cepek L, McCulloch C, M\u00f6ller HJ, Wiltfang J, Kretzschmar H, Hampel H (2006) Dissociation between CSF total Tau and Tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease. Neurobiol Aging 27:10\u20135","DOI":"10.1016\/j.neurobiolaging.2004.12.003"},{"key":"5738_CR3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","volume":"63","author":"RJ Castellani","year":"2004","unstructured":"Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P (2004) Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 63:436\u2013442","journal-title":"Neurology"},{"key":"5738_CR4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000084708","volume":"19","author":"L Cepek","year":"2005","unstructured":"Cepek L, Steinacker P, Mollenhauer B, Wiese B, Ciesielczyk B, Bibl M, Wiltfang J, Zerr I, Schulz-Schaeffer W, Kretzschmar HA, Poser S, Otto M (2005) Follow-up investigations of Tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 19:376\u2013382","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5738_CR5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000110276","volume":"10","author":"J Chapman","year":"1991","unstructured":"Chapman J, Korczyn AD (1991) Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews. Neuroepidemiology 10:228\u2013231","journal-title":"Neuroepidemiology"},{"key":"5738_CR6","first-page":"828","volume":"53","author":"R Gabizon","year":"1993","unstructured":"Gabizon R, Rosenmann H, Meiner Z, Kahana I, Kahana E, Shugart Y, Ott J, Prusiner SB (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet 53:828\u2013835","journal-title":"Am J Hum Genet"},{"key":"5738_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","volume":"60","author":"MD Geschwind","year":"2003","unstructured":"Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL (2003) Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 60:813\u2013816","journal-title":"Arch Neurol"},{"key":"5738_CR8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","volume":"30","author":"L Glodzik-Sobanska","year":"2009","unstructured":"Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Saint Louis L, Sadowski MJ, Martiniuk F, Mehta P, Pratico D, Zinkowski RP, Blennow K, de Leon MJ (2009) The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer\u2019s disease. Neurobiol Aging 30:672\u2013681","journal-title":"Neurobiol Aging"},{"key":"5738_CR9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(90)93443-S","volume":"336","author":"LG Goldfarb","year":"1990","unstructured":"Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637\u2013638","journal-title":"Lancet"},{"key":"5738_CR10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","volume":"70","author":"AJ Green","year":"2001","unstructured":"Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS (2001) Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 70:744\u2013748","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5738_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(02)00172-6","volume":"324","author":"AJ Green","year":"2002","unstructured":"Green AJ, Ramljak S, Muller WE, Knight RS, Schroder HC (2002) 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett 324:57\u201360","journal-title":"Neurosci Lett"},{"key":"5738_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1468-1331.2006.01630.x","volume":"14","author":"A Green","year":"2007","unstructured":"Green A, Sanchez-Juan P, Ladogana A, Cuadrado-Corrales N, S\u00e1nchez-Valle R, Mitrov\u00e1 E, Stoeck K, Sklaviadis T, Kulczycki J, Heinemann U, Hess K, Slivarichov\u00e1 D, Saiz A, Calero M, Mellina V, Knight R, van Duijn CM, Zerr I (2007) CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol 14:121\u2013124","journal-title":"Eur J Neurol"},{"key":"5738_CR13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199104183241604","volume":"324","author":"K Hsiao","year":"1991","unstructured":"Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R (1991) Prion protein mutation in Libyan Jews with Creutzfeldt-Jakob disease. N Eng J Med 324:1091\u20131097","journal-title":"N Eng J Med"},{"key":"5738_CR14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsiech","year":"1996","unstructured":"Hsiech G, Kenney K, Gibbs CJ Jr, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924\u2013930","journal-title":"N Engl J Med"},{"key":"5738_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.183.4120.90","volume":"183","author":"E Kahana","year":"1974","unstructured":"Kahana E, Alter M, Braham J, Sofer D (1974) Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science 183:90\u201391","journal-title":"Science"},{"key":"5738_CR16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.41.9.1390","volume":"41","author":"E Kahana","year":"1991","unstructured":"Kahana E, Zilber N, Abraham M (1991) Do Creutzfeldt-Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41:1390\u20131392","journal-title":"Neurology"},{"key":"5738_CR17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF00143127","volume":"7","author":"AD Korczyn","year":"1991","unstructured":"Korczyn AD (1991) Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol 7:490\u2013493","journal-title":"Eur J Epidemiol"},{"key":"5738_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166\u2013174","journal-title":"Hum Genet"},{"key":"5738_CR19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","volume":"256","author":"A Ladogana","year":"2009","unstructured":"Ladogana A, Sanchez-Juan P, Mitrov\u00e1 E, Green A, Cuadrado-Corrales N, S\u00e1nchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256:1620\u20131628","journal-title":"J Neurol"},{"key":"5738_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","volume":"14","author":"S Mead","year":"2006","unstructured":"Mead S (2006) Prion disease genetics. Eur J Hum Genet 14:273\u2013281","journal-title":"Eur J Hum Genet"},{"key":"5738_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00005792-199707000-00001","volume":"76","author":"Z Meiner","year":"1997","unstructured":"Meiner Z, Gabizon R, Prusiner SB (1997) Inherited Creutzfeldt-Jakob disease in Libyan Jews caused by mutation at codon 200 in the prion protein gene. Medicine (Baltimore) 76:227\u2013237","journal-title":"Medicine (Baltimore)"},{"key":"5738_CR22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/01.WNL.0000136225.80445.C9","volume":"63","author":"B Meissner","year":"2004","unstructured":"Meissner B, K\u00f6rtner K, Bartl M, Jastrow U, Mollenhauer B, Schr\u00f6ter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I (2004) Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 63:450\u2013456","journal-title":"Neurology"},{"key":"5738_CR23","first-page":"31","volume":"46","author":"E Mitrov\u00e1","year":"2002","unstructured":"Mitrov\u00e1 E, Belay G (2002) Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31\u201339","journal-title":"Acta Virol"},{"key":"5738_CR24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00415-003-1059-3","volume":"250","author":"B Mollenhauer","year":"2003","unstructured":"Mollenhauer B, Serafin S, Zerr I, Steinhoff BJ, Otto M, Scherer M, Schulz-Schaeffer WJ, Poser S (2003) Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol 250:629\u2013630","journal-title":"J Neurol"},{"key":"5738_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser (1997) Elevated levels of Tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225:210\u2013212","journal-title":"Neurosci Lett"},{"key":"5738_CR26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197","journal-title":"Neurology"},{"key":"5738_CR27","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","volume":"344","author":"SB Prusiner","year":"2001","unstructured":"Prusiner SB (2001) Shattuck lecture\u2014neurodegenerative diseases and prions. N Engl J Med 344:1516\u20131526","journal-title":"N Engl J Med"},{"key":"5738_CR28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.49.2.593","volume":"49","author":"H Rosenmann","year":"1997","unstructured":"Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R (1997) Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 49:593\u2013595","journal-title":"Neurology"},{"key":"5738_CR29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, S\u00e1anchez-Valle R, Mitrov\u00e1a E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichov\u00e1 D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637\u2013643","journal-title":"Neurology"},{"key":"5738_CR30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, S\u00e1nchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrov\u00e1 E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichov\u00e1 D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254:901\u2013906","journal-title":"J Neurol"},{"key":"5738_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000107082","volume":"24","author":"K Satoh","year":"2007","unstructured":"Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K (2007) Total Tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 24:207\u2013212","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5738_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10571-006-9370-z","volume":"26","author":"K Satoh","year":"2006","unstructured":"Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H (2006) 14-3-3 Protein, total Tau and phosphorylated Tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob Disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 26:45\u201352","journal-title":"Cell Mol Neurobiol"},{"key":"5738_CR33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","volume":"74","author":"B Everbroeck Van","year":"2003","unstructured":"Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 74:1210\u20131214","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5738_CR34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/oxfordjournals.bmb.a072655","volume":"49","author":"RG Will","year":"1993","unstructured":"Will RG (1993) Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 49:960\u2013970","journal-title":"Br Med Bull"},{"key":"5738_CR35","unstructured":"World Health Organization (1998) Consensus on criteria for sporadic CJD. WHO, Geneva"},{"key":"5738_CR36","first-page":"1551","volume":"26","author":"GS Young","year":"2005","unstructured":"Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551\u20131562","journal-title":"AJNR Am J Neuroradiol"},{"key":"5738_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32\u201340","journal-title":"Ann Neurol"},{"key":"5738_CR38","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.41.9.1385","volume":"41","author":"N Zilber","year":"1991","unstructured":"Zilber N, Kahana E, Abraham M (1991) The Libyan Creutzfeldt-Jakob disease focus in Israel: an epidemiologic evaluation. Neurology 41:1385\u20131389","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5738-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5738-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T01:07:34Z","timestamp":1559610454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["5738"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5738-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}